Z
003017
vs
S
Shanghai Composite
Over the past 12 months, Zhejiang Dayang Biotech Group Co Ltd has significantly outperformed Shanghai Composite, delivering a return of +59% compared to the Shanghai Composite's +25% growth.
Stocks Performance
003017 vs Shanghai Composite
Performance Gap
003017 vs Shanghai Composite
Performance By Year
003017 vs Shanghai Composite
Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.
Zhejiang Dayang Biotech Group Co Ltd
Glance View
Zhejiang Dayang Biotech Group Co., Ltd. engages in the production and sales of potassium salt and veterinary drugs. The company is headquartered in Hangzhou, Zhejiang and currently employs 925 full-time employees. The company went IPO on 2020-10-26. The firm's main products include potassium carbonate, potassium bicarbonate, amproline hydrochloride, 2-chloro-6-fluorobenzaldehyde, etc. Its products are used in food, pesticide, fertilizer, medicine and glass fields. The firm conducts its businesses within the Chinese market and to overseas markets.
